contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Tieto is a Nordic provider of digital services and software founded in 1968. The company is headquartered in Finland and employs experts worldwide. It serves thousands of private and public sector customers in nearly 100 countries.

The success of a counterclaim requires the same standard conditions as the success of a primary claim; therefore, insofar as it succeeds, it could have been brought as a primary claim as well. If both parties have claims against each other, it may be a matter of chance which one initiates the legal proceedings as the plaintiff of the primary claim and which one responds as the defendant and counter-claimant. Of course, a counterclaim can also sometimes be used as a means of pressure to reach a settlement. All of this is on a general level; I know nothing about the case at hand.

So, could it be thought that without that 10 million claim filed by Tieto, that 110 million counterclaim from JS BidCo wouldn’t have happened? In my opinion, these counterclaims for absurdly large sums are presented as a kind of “defensive measure,” based on following previous cases. Could it be just lawyers’ maneuvering when trying to build a case against the demands!?

Now the Tech Services business divestment—the “500 MEUR” business that was sold for 300 MEUR—is in its final stretch.  Tieto claims that 10 MEUR is missing from the price according to the terms, while the buyer, according to their own calculations in their response, claims that Tieto should pay them 110 MEUR.  Currently in arbitration…                    News Powered by Cision              Sisäpiiritieto: Päivitys välitysmenettelystä JS BidCo Oyj:tä vastaan, joka on...    Tieto Oyj   SISÄPIIRITIETO  11.5. 2026   klo 19.00     Kuten Tiedon vuoden 2026 ensimmäisen

News Powered by Cision              Microsoft ja Tieto solmivat strategisen tekoälykumppanuuden    Tieto tavoittelee asemaa Euroopan johtavana ohjelmisto- ja teknologiakonsultointiyhtiönä valituilla                             Microsoft and Tieto enter into a strategic AI partnership Reflecting the comprehensive nature of AI, the partnership between Tieto and Microsoft covers several areas, including:   Targeted co-selling of AI solutions to customers   Joint demonstrations, for example at events   Capability development, including certifications in Microsoft’s AI-enabling technologies   Efficiency and quality of software development   Utilization of AI in Tieto’s internal operations   One of the partnership’s first projects is to accelerate Tieto Tech Consulting’s business in areas that support customers’ agentic transformation and improve the productivity of digital solution development. As part of this, 5,000 consultants will be trained to utilize the latest Microsoft AI technologies. The partnership combines Tieto’s strong customer relationships and global capabilities with Microsoft’s leading AI technologies, enabling systematic, secure, and reliable value creation for customers. The collaboration covers all of Tieto’s business areas and markets.

publish.ne.cision.com              ViewReleaseInStandardHtml                              Tieto Caretech strengthens its foothold in Europe with x-tention and Better The collaboration builds a modern and interoperable clinical data platform for the DACH region. Leading digital healthcare providers Tieto Caretech, x-tention, and Better have entered into a strategic partnership to accelerate the development of next-generation open and patient-centric healthcare information systems in the DACH region (Austria, Germany, and Switzerland). The collaboration is based on the companies’ strengths and a shared commitment to promoting openness, interoperability, and data management. Together, the companies are setting a new direction for how healthcare IT solutions can evolve. Healthcare organizations in the DACH region are under increasing pressure and need to modernize outdated IT environments, break down data silos, and strengthen the utilization of clinical data. Many current patient information systems remain expensive, closed, and monolithic, which slows down innovation and digital transformation. The companies are bringing the Lifecare Open Health Suite to market, which is an open and modular ecosystem. It combines clinical and operational data using trusted international standards such as openEHR and FHIR (Fast Healthcare Interoperability Resources). Lifecare Open Health Suite offers healthcare organizations freedom of choice in an open ecosystem that is flexible, interoperable, and adaptable to future needs. By reducing vendor lock-in, interoperability is improved, and the quality of open data and interfaces is ensured. Furthermore, healthcare organizations can build a unified and patient-centric overview of care, deploy new applications in a controlled manner, reduce costs, and simplify complex IT environments. Together towards data-driven healthcare Through this collaboration, Tieto Caretech, x-tention, and Better offer healthcare providers in the DACH region the opportunity to innovate and react faster to changes in regulation and technology. This improves care outcomes from the perspective of both patients and healthcare professionals. The partnership combines the parties’ strengths in a healthcare data platform based on open standards:   Tieto Caretech’s Lifecare solutions form the core components of a modular and interoperable patient information system. The solutions have been developed in collaboration with healthcare professionals. They are widely used in the Nordic countries and comply with European healthcare legislation. Lifecare solutions support a role-based, smooth user experience and a multi-vendor environment.   x-tention brings to the partnership its strong service expertise as well as its knowledge of interoperability and the clinical operating environment. With over 20 years of experience supporting hospitals and healthcare organizations in the DACH region, x-tention combines its MACH | Orchestra integration platform with comprehensive consulting, implementation, and maintenance services. x-tention is an expert in clinical workflows, data management, and digital transformation management, making the company a key player in the development of sustainable healthcare systems based on open standards.   Better contributes the Better Platform solution, an openEHR-based clinical data repository, and a low-code development environment (Better Studio), which allows organizations to develop new applications while maintaining full ownership of their health data. Better Meds is a clinical-grade electronic prescribing and medication administration (ePMA) solution that supports medication safety, workflows, and a unified user experience across different systems.   Tieto Caretech, x-tention, and Better are committed to building a sustainable and open digital healthcare ecosystem in the DACH region. The joint roadmap includes the first combined deployments, the expansion of the multi-vendor ecosystem, and the promotion of open standards and modular architecture in Europe as an alternative to traditional monolithic solutions. The companies combine their local expertise, Nordic innovation capabilities, and leading open data technologies. The work is guided by open data, compatible systems, and truly patient-centric care.

This will also increase the share value​ Information about cancelled repurchased shares Tieto mitätöi takaisinostettuja osakkeita | Kauppalehti

News Powered by Cision              Tieto saanut päätökseen Nasdaq Tukholman listauksen arvioinnin – osakkeet...    Tietoevry Oyj                     PÖRSSITIEDOTE  24.3.2026 klo 20.15  Tieto ilmoitti 12.2.2026,                             Tieto announced on February 12, 2026, that the company’s Board of Directors was considering a potential delisting of the company’s shares from Nasdaq Stockholm. The Board has now completed its evaluation of a potential delisting. The evaluation included a review of the benefits and costs of the Nasdaq Stockholm dual listing and an overall assessment of what is in the best interests of Tieto and its shareholders. Based on the evaluation, the Board has decided that Tieto will maintain the listing of its shares on Nasdaq Stockholm. In its assessment, the Board noted that while simplifying the listing structure would support the company’s overall simplification plan, the additional benefits of a potential delisting are limited and do not warrant delisting. The Board also assessed the importance of continuing operations in the Swedish capital markets, strengthening visibility among Swedish investors, and maintaining index eligibility. The Board notes that the delisting from the Oslo Stock Exchange, approved by the Annual General Meeting on March 24, 2026, supports Tieto’s simplification plan. Tieto’s shares will remain listed on Nasdaq Helsinki and Nasdaq Stockholm, as well as on the Oslo Stock Exchange, until the delisting from Oslo is completed.            publish.ne.cision.com              ViewReleaseInStandardHtml                              Tieto Caretech will supply the City of Stockholm with a Lifecare solution and related system support for professionals in social welfare, elderly care services, and municipal healthcare. The agreement is valid for a maximum of 13 years and includes the implementation and ongoing development of the system to meet the city’s welfare service needs.

Tieto

Tieto Corporation Stock exchange release 18 May 2026 at 03:00 p.m. EET Tieto: Share repurchases on week 20 In the Helsinki Stock Exchange Date Quantity Average price Total price 11.5.2026 30...

<pre>Tieto Corporation&nbsp;&nbsp;&nbsp; Stock exchange release&nbsp;&nbsp;&nbsp; 18 May 2026 at 03:00 p.m. EET Tieto: Share repurchases on week 20 In the Helsinki Stock Exchange Date Quantity Average price Total price 11.5.2026 30 000 19,5969 587 907 12.5.2026 40 000 19,3457 773 828 13.5.2026 50 000 19,376 968 800 14.5.2026 0 0 0 15.5.2026 40 000 19,4735 778 940 Total in week 20 160 000 19,4342 3 109 475 Tieto now holds a total of 810,000 shares including the shares repurchased on 15.5.2026 The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052. On behalf of Tieto Corporation Nordea Bank Oyj Sami Huttunen Ilari Isomäki For further information, please contact: Tommi Järvenpää, Head of Investor Relations, tel. +358 40 576 0288, tommi.jarvenpaa(at)tieto.com Distribution NASDAQ Helsinki NASDAQ Helsinki Oslo Børs Principal Media Tieto is a leading software and digital engineering services company with global market reach and capabilities. We provide customers across different industries with mission-critical solutions through our specialized software businesses Tieto Caretech, Tieto Banktech and Tieto Indtech as well as Tieto Tech Consulting business. Our around 14 000 talented vertical software, design, cloud and AI experts are dedicated to empowring our customers to succeed and innovate with latest technology. Tieto`s annual revenue is approximately EUR 2 billion. The company`s shares are listed on the NASDAQ exchange &nbsp;in Helsinki and Stockholm, as well as on Oslo Børs. www.tieto.com sted on the NASDAQ\ exchange\ &nbsp;in Helsinki and Stockholm\,\ as well as on Oslo Børs.\ www.tieto.com\ </pre>